CYT X300
/ Cytospire Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
CYT X300, a novel EGFR x pan-gamma delta T cell engager for the treatment of solid tumors
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Oncology • Solid Tumor • EGFR
1 to 1
Of
1
Go to page
1